| UniProt ID | RS5_HUMAN | |
|---|---|---|
| UniProt AC | P46782 | |
| Protein Name | 40S ribosomal protein S5 | |
| Gene Name | RPS5 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 204 | |
| Subcellular Localization | ||
| Protein Description | ||
| Protein Sequence | MTEWETAAPAVAETPDIKLFGKWSTDDVQINDISLQDYIAVKEKYAKYLPHSAGRYAAKRFRKAQCPIVERLTNSMMMHGRNNGKKLMTVRIVKHAFEIIHLLTGENPLQVLVNAIINSGPREDSTRIGRAGTVRRQAVDVSPLRRVNQAIWLLCTGAREAAFRNIKTIAECLADELINAAKGSSNSYAIKKKDELERVAKSNR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MTEWETAA -------CCCCCCCC | 7.46 | 22223895 | |
| 2 | Acetylation | ------MTEWETAAP ------CCCCCCCCC | 50.21 | 19413330 | |
| 2 | Phosphorylation | ------MTEWETAAP ------CCCCCCCCC | 50.21 | 21406692 | |
| 6 | Phosphorylation | --MTEWETAAPAVAE --CCCCCCCCCCCCC | 29.23 | 20873877 | |
| 14 | Phosphorylation | AAPAVAETPDIKLFG CCCCCCCCCCEEEEC | 19.27 | 28355574 | |
| 18 | 2-Hydroxyisobutyrylation | VAETPDIKLFGKWST CCCCCCEEEECCCCC | 45.18 | - | |
| 18 | Acetylation | VAETPDIKLFGKWST CCCCCCEEEECCCCC | 45.18 | 27452117 | |
| 18 | Sumoylation | VAETPDIKLFGKWST CCCCCCEEEECCCCC | 45.18 | - | |
| 18 | Ubiquitination | VAETPDIKLFGKWST CCCCCCEEEECCCCC | 45.18 | 21890473 | |
| 22 | Ubiquitination | PDIKLFGKWSTDDVQ CCEEEECCCCCCCCE | 30.54 | 21890473 | |
| 22 | Sumoylation | PDIKLFGKWSTDDVQ CCEEEECCCCCCCCE | 30.54 | - | |
| 25 | Phosphorylation | KLFGKWSTDDVQIND EEECCCCCCCCEECC | 34.79 | 18452278 | |
| 38 | Phosphorylation | NDISLQDYIAVKEKY CCCCHHHHHHHHHHH | 4.28 | - | |
| 42 | Sumoylation | LQDYIAVKEKYAKYL HHHHHHHHHHHHHHC | 39.19 | - | |
| 42 | Acetylation | LQDYIAVKEKYAKYL HHHHHHHHHHHHHHC | 39.19 | 26051181 | |
| 42 | Ubiquitination | LQDYIAVKEKYAKYL HHHHHHHHHHHHHHC | 39.19 | 21890473 | |
| 44 | Ubiquitination | DYIAVKEKYAKYLPH HHHHHHHHHHHHCCC | 44.80 | - | |
| 45 | Phosphorylation | YIAVKEKYAKYLPHS HHHHHHHHHHHCCCH | 14.93 | - | |
| 47 | Ubiquitination | AVKEKYAKYLPHSAG HHHHHHHHHCCCHHH | 44.20 | 21906983 | |
| 47 | Acetylation | AVKEKYAKYLPHSAG HHHHHHHHHCCCHHH | 44.20 | 19608861 | |
| 47 | Sumoylation | AVKEKYAKYLPHSAG HHHHHHHHHCCCHHH | 44.20 | 28112733 | |
| 48 | Phosphorylation | VKEKYAKYLPHSAGR HHHHHHHHCCCHHHH | 19.79 | 30266825 | |
| 52 | Phosphorylation | YAKYLPHSAGRYAAK HHHHCCCHHHHHHHH | 30.40 | 30266825 | |
| 55 | Methylation | YLPHSAGRYAAKRFR HCCCHHHHHHHHHHH | 20.03 | 83108447 | |
| 56 | Phosphorylation | LPHSAGRYAAKRFRK CCCHHHHHHHHHHHH | 15.25 | - | |
| 63 | Ubiquitination | YAAKRFRKAQCPIVE HHHHHHHHCCCCHHH | 39.85 | - | |
| 66 | Glutathionylation | KRFRKAQCPIVERLT HHHHHCCCCHHHHHH | 2.72 | 22555962 | |
| 66 | S-palmitoylation | KRFRKAQCPIVERLT HHHHHCCCCHHHHHH | 2.72 | 21044946 | |
| 73 | Phosphorylation | CPIVERLTNSMMMHG CCHHHHHHHHHHHCC | 31.31 | 28450419 | |
| 75 | Phosphorylation | IVERLTNSMMMHGRN HHHHHHHHHHHCCCC | 11.65 | 28450419 | |
| 76 | Sulfoxidation | VERLTNSMMMHGRNN HHHHHHHHHHCCCCC | 2.76 | 30846556 | |
| 77 | Sulfoxidation | ERLTNSMMMHGRNNG HHHHHHHHHCCCCCC | 1.47 | 30846556 | |
| 78 | Sulfoxidation | RLTNSMMMHGRNNGK HHHHHHHHCCCCCCC | 1.96 | 30846556 | |
| 86 | Ubiquitination | HGRNNGKKLMTVRIV CCCCCCCEEEHHHHH | 44.91 | - | |
| 133 | Phosphorylation | TRIGRAGTVRRQAVD CCCCCCCCHHCCCCC | 15.17 | 26853621 | |
| 136 | Methylation | GRAGTVRRQAVDVSP CCCCCHHCCCCCCHH | 25.19 | 115492751 | |
| 142 | Phosphorylation | RRQAVDVSPLRRVNQ HCCCCCCHHHHHHHH | 17.47 | 30266825 | |
| 145 | Methylation | AVDVSPLRRVNQAIW CCCCHHHHHHHHHHH | 43.83 | 115492759 | |
| 155 | S-nitrosocysteine | NQAIWLLCTGAREAA HHHHHHHHHHHHHHH | 2.86 | - | |
| 155 | Glutathionylation | NQAIWLLCTGAREAA HHHHHHHHHHHHHHH | 2.86 | 22555962 | |
| 155 | S-nitrosylation | NQAIWLLCTGAREAA HHHHHHHHHHHHHHH | 2.86 | 22178444 | |
| 167 | Acetylation | EAAFRNIKTIAECLA HHHHHHHHHHHHHHH | 37.11 | 26051181 | |
| 167 | Ubiquitination | EAAFRNIKTIAECLA HHHHHHHHHHHHHHH | 37.11 | 21890473 | |
| 168 | Phosphorylation | AAFRNIKTIAECLAD HHHHHHHHHHHHHHH | 22.94 | 26846344 | |
| 172 | S-nitrosocysteine | NIKTIAECLADELIN HHHHHHHHHHHHHHH | 2.54 | - | |
| 172 | S-palmitoylation | NIKTIAECLADELIN HHHHHHHHHHHHHHH | 2.54 | 29575903 | |
| 172 | S-nitrosylation | NIKTIAECLADELIN HHHHHHHHHHHHHHH | 2.54 | 18335467 | |
| 172 | Glutathionylation | NIKTIAECLADELIN HHHHHHHHHHHHHHH | 2.54 | 22555962 | |
| 182 | Ubiquitination | DELINAAKGSSNSYA HHHHHHHCCCCCCCC | 57.84 | 21906983 | |
| 182 | Sumoylation | DELINAAKGSSNSYA HHHHHHHCCCCCCCC | 57.84 | 19608861 | |
| 182 | 2-Hydroxyisobutyrylation | DELINAAKGSSNSYA HHHHHHHCCCCCCCC | 57.84 | - | |
| 182 | Acetylation | DELINAAKGSSNSYA HHHHHHHCCCCCCCC | 57.84 | 26051181 | |
| 184 | Phosphorylation | LINAAKGSSNSYAIK HHHHHCCCCCCCCCC | 26.16 | 20068231 | |
| 185 | Phosphorylation | INAAKGSSNSYAIKK HHHHCCCCCCCCCCC | 38.16 | 20068231 | |
| 187 | Phosphorylation | AAKGSSNSYAIKKKD HHCCCCCCCCCCCHH | 20.21 | 28152594 | |
| 188 | Phosphorylation | AKGSSNSYAIKKKDE HCCCCCCCCCCCHHH | 19.32 | 28152594 | |
| 191 | 2-Hydroxyisobutyrylation | SSNSYAIKKKDELER CCCCCCCCCHHHHHH | 45.67 | - | |
| 191 | Sumoylation | SSNSYAIKKKDELER CCCCCCCCCHHHHHH | 45.67 | - | |
| 191 | Acetylation | SSNSYAIKKKDELER CCCCCCCCCHHHHHH | 45.67 | 25953088 | |
| 191 | Succinylation | SSNSYAIKKKDELER CCCCCCCCCHHHHHH | 45.67 | 23954790 | |
| 191 | Ubiquitination | SSNSYAIKKKDELER CCCCCCCCCHHHHHH | 45.67 | - | |
| 191 | Sumoylation | SSNSYAIKKKDELER CCCCCCCCCHHHHHH | 45.67 | - | |
| 192 | Ubiquitination | SNSYAIKKKDELERV CCCCCCCCHHHHHHH | 60.38 | - | |
| 201 | Sumoylation | DELERVAKSNR---- HHHHHHHHHCC---- | 45.46 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RS5_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RS5_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RS5_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-47, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND MASSSPECTROMETRY. | |